Alibaba Health Information Technology Limited (ALI HEALTH) filed its monthly return to the Hong Kong Stock Exchange for the period ended 31 May 2026, confirming that the company’s share capital structure remained static during the month.

• Authorised share capital stood at 20.00 billion ordinary shares with a par value of HKD 0.01, equivalent to HKD 200.00 million—unchanged from April 2026. • Issued shares (excluding treasury shares) held steady at 16.18 billion, and no treasury shares were held or cancelled. • ALI HEALTH met the Main Board’s 25 % public-float requirement.

Equity incentive activity was limited:

• Share options: 274,685 options lapsed, trimming outstanding options under two schemes to 18.63 million. No options were exercised; therefore, no new shares were issued and no funds were raised. • Restricted Share Units (RSUs): None of the 17 existing RSU grants vested during the month. A total of 117.83 million RSUs remain available for future conversion into shares.

No warrants, convertible securities, share repurchases, or other equity movements occurred in May 2026, indicating a stable capital base with zero proceeds raised for the month.